Frank Fazio

Principal

Overview

Frank Fazio is a principal of Porzio, Bromberg & Newman and a registered pharmacist in the State of New Jersey. As a member of the firm’s Life Sciences Compliance and Regulatory Counseling Department, his legal practice includes conducting third-party vendor PDMA compliance audits, counseling pharmaceutical manufacturers and wholesale distributors on licensing, record-keeping and pedigree issues, and providing guidance on OIG compliance, off-label promotion and other regulatory issues involving sales and marketing practices. A seasoned litigator, Frank also defends manufacturers in pharmaceutical and medical device product liability litigation. Frank is a frequent speaker on topics involving state, federal and international regulation of pharmaceutical sales and marketing practices.

Frank is also Vice President of Distribution and Licensing Services of Porzio Compliance Sciences, LLC, a wholly owned subsidiary of the law firm. In this role, Frank works with both emerging and established pharmaceutical companies in obtaining the necessary state distribution licensure for legend and controlled drugs, medical devices, and over-the-counter products. He also works with companies as an outsource solution for the management of renewal licensure and audits the licensure status of pharmaceutical companies and their vendors. 

Memberships

  • Union Center National Bank, Advisory Board
  • New Jersey State Bar Association, Young Lawyers Division, Treasurer, 1996–1997; Executive Committee, At-Large Representative, 1991–1996; Morris County Representative, 1996–1997; Seminars Committee, 1995–1997; Membership Committee, Co-Chair, 1996–1997; Race Judicata Committee, Chair, 1991–1994; New Jersey Lawyer, The Magazine, Editorial Board, 1996–2001
  • American Pharmacists Association
  • Congress of the Fellows of the Center for International Legal Studies, Charter Fellow
  • International Business Law Consortium
  • American Chemical Society
  • HDMA (Healthcare Distribution Management Association), Allied Member: Pozio Life Sciences

Speaking Engagements

  • "Compliance Champion Exchange," CBI's 7th Annual West Coast Compliance Congress, 11/09/2016
  • State Licensing and Other Compliance Considerations in Planning a U.S. Launch," BioWales, 3/02/2016

​​​